These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17785179

  • 1. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
    Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, Lambas-Senas L, Wiborg O, Haddjeri N, Piñeyro G, Sadikot AF, Debonnel G.
    Neuron; 2007 Sep 06; 55(5):712-25. PubMed ID: 17785179
    [Abstract] [Full Text] [Related]

  • 2. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G.
    PLoS One; 2010 Feb 16; 5(2):e9253. PubMed ID: 20169084
    [Abstract] [Full Text] [Related]

  • 3. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.
    Br J Pharmacol; 2010 Aug 16; 160(8):1929-40. PubMed ID: 20649591
    [Abstract] [Full Text] [Related]

  • 4. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
    Murata Y, Yanagihara Y, Mori M, Mine K, Enjoji M.
    J Affect Disord; 2015 Jul 15; 180():1-9. PubMed ID: 25879718
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 15; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 6. Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
    Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Römer S, Gardier AM, Hen R.
    Neuropsychopharmacology; 2014 May 15; 39(6):1366-78. PubMed ID: 24287720
    [Abstract] [Full Text] [Related]

  • 7. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP, Santos AR, Rodrigues AL.
    Brain Res Bull; 2005 Sep 30; 67(1-2):53-61. PubMed ID: 16140163
    [Abstract] [Full Text] [Related]

  • 8. A silver bullet for the treatment of depression?
    Duman RS.
    Neuron; 2007 Sep 06; 55(5):679-81. PubMed ID: 17785173
    [Abstract] [Full Text] [Related]

  • 9. Effects of a putative antidepressant with a rapid onset of action in defeated mice with different coping strategies.
    Gómez-Lázaro E, Garmendia L, Beitia G, Perez-Tejada J, Azpiroz A, Arregi A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):317-27. PubMed ID: 22561232
    [Abstract] [Full Text] [Related]

  • 10. [Antidepressants, stressors and the serotonin 1A receptor].
    Kirilly E, Gonda X, Bagdy G.
    Neuropsychopharmacol Hung; 2015 Jun 07; 17(2):81-9. PubMed ID: 26192901
    [Abstract] [Full Text] [Related]

  • 11. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.
    Assié MB, Lomenech H, Ravailhe V, Faucillon V, Newman-Tancredi A.
    Br J Pharmacol; 2006 Sep 07; 149(2):170-8. PubMed ID: 16921393
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ, Tohyama Y, Watanabe A, Hasegawa S, Skelin I, Diksic M.
    Neurochem Int; 2009 Sep 07; 54(3-4):161-71. PubMed ID: 19073228
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist.
    Chen HX, Jin ZL, Zhang LM, Xue R, Xu XD, Zhao N, Qiu ZK, Wang XW, Zhang YZ, Yang RF, Li YF.
    PLoS One; 2013 Sep 07; 8(12):e83271. PubMed ID: 24367588
    [Abstract] [Full Text] [Related]

  • 14. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.
    Starr KR, Price GW, Watson JM, Atkinson PJ, Arban R, Melotto S, Dawson LA, Hagan JJ, Upton N, Duxon MS.
    Neuropsychopharmacology; 2007 Oct 07; 32(10):2163-72. PubMed ID: 17356576
    [Abstract] [Full Text] [Related]

  • 15. Serotonin 2C receptor antagonists induce fast-onset antidepressant effects.
    Opal MD, Klenotich SC, Morais M, Bessa J, Winkle J, Doukas D, Kay LJ, Sousa N, Dulawa SM.
    Mol Psychiatry; 2014 Oct 07; 19(10):1106-14. PubMed ID: 24166413
    [Abstract] [Full Text] [Related]

  • 16. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508
    [Abstract] [Full Text] [Related]

  • 17. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 18. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
    Qin JJ, Chen HX, Zhao N, Yuan L, Zhang YZ, Yang RF, Zhang LM, Li YF.
    Neurosci Lett; 2014 Oct 17; 582():104-8. PubMed ID: 25220701
    [Abstract] [Full Text] [Related]

  • 19. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
    Bermack JE, Haddjeri N, Debonnel G.
    J Pharmacol Exp Ther; 2004 Aug 17; 310(2):578-83. PubMed ID: 15044555
    [Abstract] [Full Text] [Related]

  • 20. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL.
    Neuropsychopharmacology; 2008 Sep 17; 33(10):2303-12. PubMed ID: 18059438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.